BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19447827)

  • 1. Development of quality indicators for monitoring of the disease course in rheumatoid arthritis.
    van Hulst LT; Fransen J; den Broeder AA; Grol R; van Riel PL; Hulscher ME
    Ann Rheum Dis; 2009 Dec; 68(12):1805-10. PubMed ID: 19447827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis.
    Khanna D; Arnold EL; Pencharz JN; Grossman JM; Traina SB; Lal A; MacLean CH
    Semin Arthritis Rheum; 2006 Feb; 35(4):211-37. PubMed ID: 16461068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-based development of quality indicators for subfertility care.
    Mourad SM; Hermens RP; Nelen WL; Braat DD; Grol RP; Kremer JA
    Hum Reprod; 2007 Oct; 22(10):2665-72. PubMed ID: 17664242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel.
    Cabral D; Katz JN; Weinblatt ME; Ting G; Avorn J; Solomon DH
    Arthritis Rheum; 2005 Feb; 53(1):61-6. PubMed ID: 15696560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCORT/CCS quality indicators for congestive heart failure care.
    Lee DS; Tran C; Flintoft V; Grant FC; Liu PP; Tu JV;
    Can J Cardiol; 2003 Mar; 19(4):357-64. PubMed ID: 12704479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
    Kahn KL; MacLean CH; Liu H; Rubenstein LZ; Wong AL; Harker JO; Chen WP; Fitzpatrick DM; Bulpitt KJ; Traina SB; Mittman BS; Hahn BH; Paulus HE
    Arthritis Rheum; 2006 Dec; 55(6):884-91. PubMed ID: 17139665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.
    Adhikesavan LG; Newman ED; Diehl MP; Wood GC; Bili A
    Arthritis Rheum; 2008 Dec; 59(12):1705-12. PubMed ID: 19035412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.
    Kahn KL; Maclean CH; Wong AL; Rubenstein LZ; Liu H; Fitzpatrick DM; Harker JO; Chen WP; Traina SB; Mittman BS; Hahn BH; Paulus HE
    Arthritis Rheum; 2007 Jun; 57(5):707-15. PubMed ID: 17530663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
    Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
    Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis.
    Uhlig T; Moe R; Reinsberg S; Kvien TK; Cieza A; Stucki G
    Ann Rheum Dis; 2009 Jun; 68(6):879-84. PubMed ID: 18625628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of guideline-based indicators for patient-centredness in fertility care: what patients add.
    den Breejen EM; Nelen WL; Schol SF; Kremer JA; Hermens RP
    Hum Reprod; 2013 Apr; 28(4):987-96. PubMed ID: 23411619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence.
    Caplin DA; Rao JK; Filloux F; Bale JF; Van Orman C
    Epilepsia; 2006 Dec; 47(12):2011-9. PubMed ID: 17201697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of generic quality indicators for patient-centered cancer care by using a RAND modified Delphi method.
    Uphoff EP; Wennekes L; Punt CJ; Grol RP; Wollersheim HC; Hermens RP; Ottevanger PB
    Cancer Nurs; 2012; 35(1):29-37. PubMed ID: 21558851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care?
    Sokka T
    Rheum Dis Clin North Am; 2010 May; 36(2):243-57. PubMed ID: 20510232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
    Flendrie M; Creemers MC; van Riel PL
    Rheumatology (Oxford); 2007 Jan; 46(1):146-9. PubMed ID: 16782732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of standards by the Norwegian Society of Rheumatology. Control of disease modifying drugs].
    Kvien TK; Haga HJ; Kvalvik AG
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2315-8. PubMed ID: 8804206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.